PDS Biotechnology (PDSB) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts PDSB Hot Sheet
Join SI Premium – FREE
PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue
- HSBC Downgrades IBM (IBM) to Reduce
- Molina Healthcare (MOH) PT Raised to $230 at TD Cowen
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
